A Study to Compare Pharmacokinetics, Pharmacodynamics and Safety of UI059 and UIC202201 in Healthy Subjects

Inclusion Criteria: * healthy adult volunteers aged 19 and above. * For males, a weight of 50.0 kg or more, and for females, a weight of 45.0 kg or more, with a body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2. BMI(kg/m2)=Weight(kg)/height(m)2 * No congenital or chronic diseases requiring treatment, and no pathological symptoms or findings based on internal medicine examination. * Those who were determined to be suitable subjects for clinical trials as a result of tests such as clinical laboratory tests, vital signs, physical examination (physical examination), and 12-lead electrocardiogram * Negative for H. pylori antibodies * After receiving detailed explanations about the clinical trial and fully understanding, participants voluntarily decide to participate and provide written consent to adhere to the subject compliance requirements throughout the trial period. Exclusion Criteria: * Current or past medical history of clinically significant conditions involving the liver, kidneys, nervous system, mental health, respiratory system, endocrine system, blood disorders, tumors, genitourinary system, cardiovascular system, digestive system, musculoskeletal system, etc., and in addition: * currently receiving antiretroviral drugs (rilpivirine, atazanavir, nelfinavir) * liver disorders * kidney disorders * History of gastrointestinal conditions (Crohn's disease, ulcers, acute or chronic pancreatitis) or gastrointestinal surgery (excluding simple appendectomy or h…